Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fabric.AI, Inc.FABC · Entity 7732 | Director | June 18, 2026 | June 18, 2026 |
| Outdoor Holding CoPOWW · Entity 6124 | Director | August 17, 2026 | August 19, 2026 |
| PITNEY BOWES INC /DE/PBI · Entity 4392 | Director | September 22, 2026 | September 23, 2026 |
| Petros Pharmaceuticals, Inc.PTPI · Entity 8730 | Director | June 05, 2026 | June 08, 2026 |
| PharmaCyte Biotech, Inc.PMCB · Entity 8256 | Director | March 31, 2026 | July 17, 2026 |
| WRAP TECHNOLOGIES, INC.WRAP · Entity 6770 | PRIOR DIRECTOR | September 30, 2023 | October 19, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fabric.AI, Inc.
Report date June 18, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $3.70 · Expires 2036-06-18 | Direct | 45,042 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 45,042 · Balance 45,042 F1: The stock options vest as follows: (i) 25% vested upon the date of grant; (ii) 25% will vest on June 30, 2026, (iii) 25% will vest on September 30, 2026, and (iv) 25% will vest on December 31, 2026, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options vest as follows: (i) 25% vested upon the date of grant; (ii) 25% will vest on June 30, 2026, (iii) 25% will vest on September 30, 2026, and (iv) 25% will vest on December 31, 2026, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date.
Outdoor Holding Co
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,413 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Grant · Acquired 15,000 · Balance 191,413 F1: Reflects the grant of 15,000 shares of common stock that members of the issuer's Board of Directors (the "Board") receive quarterly as part of their annual compensation for Board service. The reporting person pays no consideration for these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of 15,000 shares of common stock that members of the issuer's Board of Directors (the "Board") receive quarterly as part of their annual compensation for Board service. The reporting person pays no consideration for these shares.
PITNEY BOWES INC /DE/
Report date September 22, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,601 |
Reported balance
After 2026-09-22 transaction · row 1
1 source rowRow 1 · 2026-09-22 · Exercise / conversion · Acquired 5,601 · Balance 5,601 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-09-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-22 · Exercise / conversion · Disposed 5,601 · Balance 0 F1: Each unit represents a contingent right to receive one share of Pitney Bowes common stock. F2: Restricted Stock Units granted to non-employee directors on September 22, 2025 cliff vested according to schedule on September 22, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents a contingent right to receive one share of Pitney Bowes common stock.
F2: Restricted Stock Units granted to non-employee directors on September 22, 2025 cliff vested according to schedule on September 22, 2026.
Petros Pharmaceuticals, Inc.
Report date June 05, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 881,333 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 375,000 · Balance 881,333 F1: Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date.
PharmaCyte Biotech, Inc.
Report date March 31, 2026 · Filed July 17, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-31 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-03-31 · Other · Acquired 0 · Balance 0 F1: The reported grant was made in error and has been cancelled. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported grant was made in error and has been cancelled.
WRAP TECHNOLOGIES, INC.
Report date September 30, 2023 · Filed October 19, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,575 |
Ending reported balance
After 2023-10-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-09-30 · Grant · Acquired 10,083 · Balance 112,968 F1: Represents shares of Restricted Stock (the "Shares") issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023. The number of Shares was calculated based on the amount due the Reporting Person at the end of the quarter, or $15,125, divided by the closing price of the Company's Common Stock on such date. 30% of the Shares were vested as of the date of the grant, with the remainder vesting ratably in eight monthly tranches beginning November 1, 2023. Row 2 · 2023-10-12 · Grant · Acquired 21,607 · Balance 134,575 F2: Represents shares of Restricted Stock issued in connection with the Reporting Person's resignation from the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Restricted Stock (the "Shares") issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023. The number of Shares was calculated based on the amount due the Reporting Person at the end of the quarter, or $15,125, divided by the closing price of the Company's Common Stock on such date. 30% of the Shares were vested as of the date of the grant, with the remainder vesting ratably in eight monthly tranches beginning November 1, 2023.
F2: Represents shares of Restricted Stock issued in connection with the Reporting Person's resignation from the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2022 Filed Nov 18, 2022 22:14 UTC | WRAP TECHNOLOGIES, INC. WRAP · Entity 6770 | GrantCommon Stock | 8,845 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-011600 · form4-11182022_101121.xml · nonDerivative · entry 3 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,781 F3 · price: Represents shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2022. The number of shares was calculated based on the amount due the Reporting Person at the end of the quarter, or $15,125, divided by the closing price of the Company's Common Stock on such date. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 22:14 UTC | WRAP TECHNOLOGIES, INC. WRAP · Entity 6770 | GrantCommon Stock | 8,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-011600 · form4-11182022_101121.xml · nonDerivative · entry 2 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,936 F2 · price: Represents shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2022. The number of shares was calculated based on the amount due the Reporting Person at the end of the quarter, or $15,125, divided by the closing price of the Company's Common Stock on such date. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 22:14 UTC | WRAP TECHNOLOGIES, INC. WRAP · Entity 6770 | GrantCommon Stock | 5,602 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-011600 · form4-11182022_101121.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,804 F1 · price: Represents shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended March 31, 2022. The number of shares was calculated based on the amount due the Reporting Person at the end of the quarter, or $15,125, divided by the closing price of the Company's Common Stock on such date. Read SEC document |
| November 01, 2022 Filed Nov 4, 2022 00:31 UTC | Fabric.AI, Inc. AYRO · Entity 7732 | SaleCommon Stock | 4,094 | $0.59 | $2,423.24 |
DisclosureSEC source: 0001493152-22-030394 · ownership.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,910 F1 · shares: Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on August 22, 2022 to pay taxes upon the vesting of an award. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 21:01 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantRestricted Stock Units · Derivative | 60,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-044717 · tm2212468d4_4.xml · derivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,505 Underlying: Common Stock · 60,505 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer. F2 · derivative.exercise_date: The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date. F2 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 17:10 UTC | Fabric.AI, Inc. AYRO · Entity 7732 | GrantCommon Stock | 65,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-003067 · ownership.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,004 F1 · shares: Shares will vest in four equal installments on each quarterly anniversary of the Grant Date, provided that Mr. Walker is employed by or providing services to the Company through the applicable vesting date and subject to the terms and conditions of the AYRO, Inc. Long-Term Incentive Plan. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:15 UTC | Fabric.AI, Inc. AYRO · Entity 7732 | SaleCommon Stock | 1,625 | $1.63 | $2,654.11 |
DisclosureSEC source: 0001493152-22-000674 · ownership.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,500 F1 · shares: Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on June 15, 2021 to pay taxes upon the vesting of an award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.655, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 22, 2021 Filed Jan 7, 2022 21:45 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantRestricted Stock Units · Derivative | 22,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-002307 · tm222320d4_4.xml · derivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,642 Underlying: Common Stock · 22,642 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer. F2 · derivative.exercise_date: The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date F2 · derivative.expiration_date: The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 23:37 UTC | Fabric.AI, Inc. AYRO · Entity 7732 | SaleCommon Stock | 1,625 | $3.20 | $5,198.21 |
DisclosureSEC source: 0001493152-21-024990 · ownership.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,125 F1 · shares: Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on June 15, 2021 to pay taxes upon the vesting of an award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.25, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 04, 2021 Filed Aug 9, 2021 13:00 UTC | Fabric.AI, Inc. AYRO · Entity 7732 | SaleCommon Stock | 3,250 | $4.30 | $13,970.45 |
DisclosureSEC source: 0001493152-21-018992 · ownership.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 F1 · shares: Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on June 15, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.22 to $4.36, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 20:17 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001567619-21-007865 · doc1.xml · derivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-08 F1 · derivative.exercise_date: The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:39 UTC | WRAP TECHNOLOGIES, INC. WRAP · Entity 6770 | GrantCommon Stock | 10,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001900 · form4-04052021_050430.xml · nonDerivative · entry 2 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,202 F2 · shares: Represents grant of restricted stock issued in connection with the Reporting Person's service on the Issuer's Board of Directors. 30% of the restricted stock vest on the date of the grant, with the remainder vesting in eight equal monthly installments thereafter, becoming fully vested on December 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:39 UTC | WRAP TECHNOLOGIES, INC. WRAP · Entity 6770 | GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001900 · form4-04052021_050430.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,320 F1 · shares: Represents shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:33 UTC | Fabric.AI, Inc. AYRO · Entity 7732 | GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-004999 · ownership.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · shares: Represents restricted shares of common stock granted to the reporting person. 50% of such shares vest on June 30, 2021, and the remaining shares vest in two equal quarterly installments over the following six months. Read SEC document |
| January 16, 2020 Filed Jan 18, 2020 01:24 UTC | WRAP TECHNOLOGIES, INC. WRTC · Entity 6770 | GrantCommon Stock | 10,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000144 · form4-01172020_050116.xml · nonDerivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,070 F1 · kind: Represents grant of restricted stock units. Shares will be issued upon vesting, and shall vest as follows: (i) 1/3 one year from the date of grant, and (ii) the remaining 2/3 in equal installments every six months over the two-year period thereafter. Read SEC document |
| November 14, 2018 Filed Nov 26, 2018 23:26 UTC | WRAP TECHNOLOGIES, INC. WRTC · Entity 6770 | GrantStock Options · Derivative | 35,000 | Not disclosed Strike: $3.61 | Not disclosed |
DisclosureSEC source: 0001415889-18-001684 · form4-11262018_031119.xml · derivative · entry 1 WALKER WAYNE REMELL · CIK 0001428761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2023-11-14 F2 · price: The Stock Options reported herein were issued in connection with the Reporting Person's appointment to the Issuer's Board of Directors and pursuant to the Issuer's 2017 Equity Compensation Plan. F1 · derivative.exercise_date: The Stock Options shall vest as follows: 50% on the one-year anniversary of the grant date, with the remainder vesting in four equal quarterly tranches over the following 12 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.